Investors
-
Regulatory November 10, 2023 EnglishINITIATOR PHARMA: Q3 2023 REPORT
-
Regulatory October 6, 2023 EnglishInitiator Pharma reports positive statistically significant and clinically relevant Phase IIb efficacy data with pudafensine
-
Non Regulatory September 25, 2023 EnglishResult of incentive program LTI2023 in Initiator Pharma
-
Regulatory November 10, 2023 EnglishINITIATOR PHARMA: Q3 2023 REPORT
-
Regulatory August 25, 2023 EnglishINITIATOR PHARMA: Q2 2023 REPORT
-
Regulatory May 5, 2023 EnglishINITIATOR PHARMA: Q1 2023 REPORT
Initiator Pharma Numbers
-
Expected Number of men affected by Erectile Dysfunction worldwide by 2025 322 million
-
Number of people worldwide that are diagnosed with Trigeminal Neuralgia every year: 15000
-
Men with Erectile Dysfunction who do not respond to drug therapy 40 %